You just read:

TCR2 Therapeutics Named One of the 15 Innovative Immuno-Oncology Biotechs to Watch in 2018 by Immuno-Oncology Frontiers

News provided by

TCR2 Therapeutics

Sep 15, 2017, 10:07 ET